Laboratory evaluation of panidazole (1-(2'-( -pyridyl) ethyl-2-methyl)-5-nitroimidazole), a new amoebicide.
D000562:Amebiasis / Q000188:drug therapy*; D000563:Amebicides / Q000494:pharmacology*; D000818:Animals; D000994:Antitrichomonal Agents / Q000494:pharmacology; D002429:Cecal Diseases / Q000188:drug therapy; D006224:Cricetinae; D004640:Emetine / Q000627:therapeutic use; D004748:Entamoeba histolytica / Q000187:drug effects*; D007093:Imidazoles / Q000494:pharmacology*; D008101:Liver Abscess, Amebic / Q000188:drug therapy; D008795:Metronidazole / Q000627:therapeutic use; D051379:Mice; D008826:Microbial Sensitivity Tests; D051381:Rats; D011919:Rats, Inbred Strains; D014245:Trichomonas Infections / Q000188:drug therapy; D014246:Trichomonas vaginalis / Q000187:drug effects*; D014352:Trypanosomiasis / Q000188:drug therapy
D000563:Amebicides; D000994:Antitrichomonal Agents; D007093:Imidazoles; D008795:Metronidazole; D004640:Emetine